Tildrakizumab

Sun Pharma and China Medical System Holdings enter into a License Agreement for Tildrakizumab in Greater China

Relationship gives Sun Pharma access to Greater China market for Tildrakizumab China to become a key market in future with…

5 years ago

Why 2018 will be a challenging year for pharmaceuticals

New Delhi, March 29, 2018: Management teams were generally optimistic on the outlook for domestic Indian markets, with sales growth…

7 years ago